The OS curves presented in Figure 6D-F indicate that high expressions levels of HMGA1, LRFN4, PKP3, DNASE2B, SNTN, VSIG2, and ERO1A were associated with an impaired prognosis (log-rank p < 0.05) for NSCLC patients. Here, ERO1A is linked to non-small cell lung carcinoma.